| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Dec 19, 2025 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -910 | -3.89% | ✗ | $455.5K |
| Sep 10, 2025 | Sep 10, 2025 | UNITED THERAPEUTICS Corp | Director | Sell | 17.5 | -4,560 | -16.86% | ✗ | $1.8M |
| May 28, 2025 | May 28, 2025 | HEALTHPEAK PROPERTIES, INC. | Director | Buy | 87.5 | +5,777 | 4.17% | ✗ | $99.8K |
| May 9, 2025 | May 12, 2025 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,500 | -10.01% | ✗ | $762.9K |
| May 9, 2025 | May 12, 2025 | HEALTHPEAK PROPERTIES, INC. | Director | Buy | 87.5 | +5,700 | 4.29% | ✗ | $99K |
| Apr 14, 2025 | Apr 15, 2025 | TherapeuticsMD, Inc. | Director | Buy | 77.5 | +325 | 1.13% | ✗ | $325.6 |
| Mar 24, 2025 | Mar 25, 2025 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,500 | -10.01% | ✗ | $797K |
| Feb 28, 2025 | Mar 3, 2025 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,500 | -10.01% | ✗ | $795.8K |
| Jun 26, 2024 | Jun 28, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 17.5 | -7,500 | -25.02% | ✗ | $2.4M |
| Mar 11, 2024 | Mar 12, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 17.5 | -5,000 | -37.09% | ✗ | $1.2M |
| Mar 8, 2024 | Mar 11, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,000 | -8.17% | ✗ | $486.1K |
| Mar 6, 2024 | Mar 7, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,000 | -8.17% | ✗ | $473.9K |
| Mar 1, 2024 | Mar 4, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,000 | -8.17% | ✗ | $463.8K |
| Feb 23, 2024 | Feb 26, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,000 | -8.17% | ✗ | $454.1K |
| Jun 13, 2023 | Jun 14, 2023 | UNITED THERAPEUTICS Corp | Director | Sell | 22.5 | -1,000 | -4.42% | ✗ | $229.5K |
| Jun 2, 2023 | Jun 5, 2023 | UNITED THERAPEUTICS Corp | Director | Sell | 22.5 | -1,000 | -4.42% | ✗ | $217.2K |
| Mar 24, 2023 | Apr 3, 2023 | UNITED THERAPEUTICS Corp | Director | Sell | 17.5 | -5,000 | -14.62% | ✗ | $1.1M |
| Mar 3, 2023 | Mar 6, 2023 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,500 | -10.37% | ✗ | $621.7K |
| Feb 28, 2023 | Mar 1, 2023 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,500 | -10.37% | ✗ | $615.1K |
| Nov 23, 2022 | Nov 25, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 17.5 | -5,000 | -18.80% | ✗ | $1.3M |
| May 26, 2022 | May 26, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,200 | -9.68% | ✗ | $494.5K |
| Mar 29, 2022 | Mar 30, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -1,500 | -6.81% | ✗ | $267.7K |
| Mar 16, 2022 | Mar 18, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -3,009 | -10.01% | ✗ | $552.2K |
| Mar 15, 2022 | Mar 16, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -1,500 | -6.81% | ✗ | $268.2K |
| Mar 10, 2022 | Mar 11, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 22.5 | -1,000 | -4.65% | ✗ | $167.8K |
| Mar 3, 2022 | Mar 4, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -1,500 | -6.81% | ✗ | $262.4K |
| Aug 13, 2021 | Aug 17, 2021 | TherapeuticsMD, Inc. | Director | Buy | 77.5 | +11,000 | 1.29% | ✗ | $9.6K |
| May 14, 2021 | May 18, 2021 | TherapeuticsMD, Inc. | Director | Buy | 67.5 | +5,000 | 0.71% | ✗ | $5.3K |
| Mar 10, 2021 | Mar 11, 2021 | UNITED THERAPEUTICS Corp | Director | Sell | 17.5 | -12,350 | -39.60% | ✗ | $2M |
| Sep 30, 2020 | Oct 2, 2020 | CENTENE CORP | Director | Sell | 50.0 | -936 | -0.24% | ✓ | $87.5K |
| Jun 30, 2020 | Jul 2, 2020 | CENTENE CORP | Director | Sell | 48.8 | -962 | -0.25% | ✓ | $96.2K |
| Jun 9, 2020 | Jun 10, 2020 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -4,210 | -18.26% | ✗ | $533.8K |
| Jun 4, 2020 | Jun 8, 2020 | TherapeuticsMD, Inc. | Director | Buy | 77.5 | +8,700 | 1.25% | ✗ | $9.8K |
| May 5, 2020 | May 5, 2020 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -3,100 | -11.85% | ✗ | $348.9K |
| Apr 6, 2020 | Apr 8, 2020 | CENTENE CORP | Director | Sell | 48.8 | -1,500 | -0.39% | ✓ | $87K |
| Mar 2, 2020 | Mar 4, 2020 | CENTENE CORP | Director | Sell | 53.8 | -500 | -0.13% | ✓ | $26.7K |
| Mar 2, 2020 | Mar 3, 2020 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -4,290 | -14.09% | ✗ | $444.4K |
| Feb 6, 2020 | Feb 10, 2020 | CENTENE CORP | Director | Sell | 53.8 | -500 | -0.13% | ✓ | $32.9K |
| Dec 31, 2019 | Jan 3, 2020 | CENTENE CORP | Director | Sell | 48.8 | +145 | 0.04% | ✓ | $31.5K |
| Aug 9, 2019 | Aug 13, 2019 | TherapeuticsMD, Inc. | Director | Buy | 68.8 | +5,000 | 0.73% | ✗ | $15.2K |
| May 13, 2019 | May 14, 2019 | TherapeuticsMD, Inc. | Director | Buy | 60.0 | +2,400 | 0.35% | ✗ | $8K |
| Aug 21, 2018 | Aug 23, 2018 | TherapeuticsMD, Inc. | Director | Buy | 68.8 | +4,000 | 0.59% | ✗ | $22.1K |
| Dec 8, 2017 | Dec 11, 2017 | TherapeuticsMD, Inc. | Director | Buy | 68.8 | +5,000 | 0.74% | ✗ | $31.1K |
| Aug 30, 2017 | Sep 1, 2017 | TherapeuticsMD, Inc. | Director | Buy | 68.8 | +5,000 | 0.74% | ✗ | $30K |
| Sep 3, 2015 | Sep 8, 2015 | PLUS THERAPEUTICS, INC. | Director | Buy | 90.0 | +25,449 | 43.76% | ✗ | $9.5K |
| Aug 20, 2015 | Aug 24, 2015 | TherapeuticsMD, Inc. | Director | Buy | 95.0 | +10,798 | 226.99% | ✗ | $68K |
| May 11, 2015 | May 12, 2015 | TherapeuticsMD, Inc. | Director | Buy | 68.8 | +6,000 | 0.91% | ✗ | $36.5K |
| Sep 4, 2014 | Sep 8, 2014 | TherapeuticsMD, Inc. | Director | Buy | 55.0 | +1,757 | 0.13% | ✗ | $9.6K |
| May 8, 2014 | May 9, 2014 | TherapeuticsMD, Inc. | Director | Buy | 82.5 | +14,000 | 2.22% | ✗ | $50K |
| Mar 14, 2013 | Dec 17, 2013 | TherapeuticsMD, Inc. | Director | Buy | 90.0 | +30,000 | 5.00% | ✗ | $51K |
| Aug 30, 2013 | Sep 3, 2013 | PLUS THERAPEUTICS, INC. | Director | Buy | 91.3 | +5,000 | 12.45% | ✗ | $10.7K |
| Apr 1, 2013 | Apr 1, 2013 | CareView Communications Inc | Director | Buy | 60.0 | +20,202 | 0.42% | ✗ | $10K |
| Aug 19, 2011 | Aug 23, 2011 | PLUS THERAPEUTICS, INC. | Director | Buy | 90.0 | +3,050 | 14.52% | ✗ | $9.9K |
| Jul 1, 2009 | Jul 6, 2009 | PURE BIOSCIENCE, INC. | Director | Sell | 52.5 | -5,000 | -0.84% | ✓ | $9K |
| Jan 9, 2009 | Jan 13, 2009 | PURE BIOSCIENCE, INC. | Director | Sell | 22.5 | -29,963 | -2.55% | ✗ | $97.8K |
| Jan 7, 2009 | Jan 12, 2009 | PURE BIOSCIENCE, INC. | Director | Sell | 22.5 | -35,000 | -2.82% | ✗ | $116.8K |
| Jan 7, 2009 | Jan 12, 2009 | PURE BIOSCIENCE, INC. | Director | Buy | 87.5 | +35,000 | 2.99% | ✗ | $116.8K |
| Oct 21, 2008 | Oct 23, 2008 | PURE BIOSCIENCE, INC. | Director | Sell | 22.5 | -30,000 | -4.37% | ✗ | $92.9K |
| Jul 24, 2008 | Jul 28, 2008 | PURE BIOSCIENCE, INC. | Director | Sell | 22.5 | -30,000 | -4.02% | ✗ | $155K |
| Apr 1, 2008 | Apr 3, 2008 | PURE BIOSCIENCE, INC. | Director | Sell | 25.0 | -25,000 | -11.57% | ✓ | $149.6K |
| Mar 24, 2008 | Mar 26, 2008 | PURE BIOSCIENCE, INC. | Director | Sell | 37.5 | -22,500 | -4.95% | ✓ | $113.7K |
| Mar 3, 2008 | Mar 5, 2008 | PURE BIOSCIENCE, INC. | Director | Sell | 48.8 | -2,500 | -1.04% | ✓ | $12.5K |
| Feb 1, 2008 | Feb 5, 2008 | PURE BIOSCIENCE, INC. | Director | Sell | 22.5 | -25,000 | -13.51% | ✗ | $135.8K |
| Jan 22, 2008 | Jan 24, 2008 | PURE BIOSCIENCE, INC. | Director | Sell | 22.5 | -25,000 | -10.64% | ✗ | $132.4K |